Savara (SVRA) just unveiled an update.
Dr. Ricky Sun has informed Savara Inc. that he will not seek re-election to the Board of Directors after his term ends at the 2024 Annual Meeting, a decision made without any conflicts regarding the company’s operations, policies, or practices. In a significant corporate development, Bain Capital Life Sciences has chosen to permanently waive its right, as per a 2019 Securities Purchase Agreement, to nominate a board member as long as they maintain a substantial shareholding in Savara Inc., signaling a shift in the company’s governance dynamics.
For an in-depth examination of SVRA stock, go to TipRanks’ Stock Analysis page.
